Individual PWV results (m/sec) in each group at baseline, 12 weeks and 12 months (9-month follow-up).

<p><b>(A)</b> UC group (n = 20), <b>(B)</b> AT group (n = 12), and <b>(C)</b> RT group (n = 10).</p

Long-term outcomes at 9-month follow-up-, and results of 9-month follow-up ANCOVA analysis.

<p>Long-term outcomes at 9-month follow-up-, and results of 9-month follow-up ANCOVA analysis.</p

Participant baseline demographics and 9-month follow-up outcomes.

<p>Participant baseline demographics and 9-month follow-up outcomes.</p

CONSORT flow diagram.

<p>Demonstrating flow of participants throughout the study at baseline, 12 weeks, 12 months (9-month follow-up), and those included in final analysis.</p

Individual PWV results (m/sec) in each group at baseline, 12 weeks and 12 months (9-month follow-up).

<p><b>(A)</b> UC group (n = 20), <b>(B)</b> AT group (n = 12), and <b>(C)</b> RT group (n = 10).</p

Individual relative VO2peak values (ml/min/kg) in each group at baseline, 12 weeks and 12 months (9-month follow-up).

<p><b>(A)</b> UC group (n = 20), <b>(B)</b> AT group (n = 9), and <b>(C)</b> RT group (n = 8).</p

Bland-Altman analysis of observed/predicted Hb values.

<p>Bland-Altman analysis of observed/predicted Hb values.</p

Baseline patient characteristics.

<p>Baseline patient characteristics.</p

Steps involved in the development and validation of the Artificial Neural Network anemia modeling.

<p>Steps involved in the development and validation of the Artificial Neural Network anemia modeling.</p

Predicting performances of ANN modeling at patient level.

<p>Predicting performances of ANN modeling at patient level.</p